EMCDDA news

EMCDDA preparedness and response to a fast-moving drugs problem

Revolutionary changes, both in the extent and nature of the drugs problem, and in the world in which we live, have called for constant reflection, innovation and agility to keep pace with new developments and rethink existing routines. This is why the EMCDDA has adopted a multi-indicator approach to monitoring in its response to a fast-moving drugs problem.
Čtěte více

European Drugs Summer School 2020 to switch to remote teaching

The European Drugs Summer School (EDSS) will switch to remote teaching this year in an effort to help curb the spread of COVID-19 and reduce pressure on health services. The 2020 EDSS — organised by the EMCDDA and the University Institute of Lisbon (ISCTE-IUL) — will run from 29 June to 10 July. Under the general theme ‘Illicit drugs in Europe: demand, supply and public policies’, the 2020 course will provide a multi-disciplinary approach to the study of the drugs problem in Europe and beyond. The focus this year will be on hepatitis C. 23.04.2020 
Čtěte více

EMCDDA launches COVID-19 special round of European Web Survey on Drugs to assess impact of pandemic

Crucial information on the impact of COVID-19 on people who use drugs, and on the services that support them, will be collected via a special round of the European Web Survey on Drugs, launched this week. The survey — the Mini European Web Survey on Drugs: COVID-19 — is coordinated by the EMCDDA in collaboration with its Reitox network of national focal points. 16.04.2020 
Čtěte více

Dne 2. července 2024 se centrum EMCDDA stalo Agenturou Evropské unie pro drogy (EUDA).
Web agentury: https://www.euda.europa.eu Informační stránka o novém mandátu centra EMCDDA (agentury EUDA) je na webu EUDA k dispozici i v češtině - OTEVŘÍT Změnily se i e-mailové adresy zaměstnanců agentury, jsou nyní ve formátu jmeno.prijmeni@euda.europa.eu.